
A549 cell membrane-camouflaged Mn2+-doped Prussian blue/polydopamine-chlorin e6 nanoparticles (MnPB-PDA-Ce6@CCM) were developed as a biomimetic, light-responsive delivery system. MnPB nanoparticles were modified with polydopamine, conjugated with chlorin e6 (Ce6), and coated with A549 cell membranes by membrane extrusion. The formulation was optimized using a Box-Behnken design. Under the optimized conditions, MnPB-PDA-Ce6 exhibited a drug loading of 14.16 +/- 0.42%, an encapsulation efficiency of 80.13 +/- 0.25%, and a particle size of 38.25 +/- 0.56 nm. Membrane coating increased the particle size to 50.26 +/- 0.33 nm and produced a polydispersity index of 0.181 and a zeta potential of -25.97 +/- 1.8 mV. Complementary physicochemical and protein analyses supported nanoparticle assembly and retention of A549 membrane-associated proteins. MnPB-PDA-Ce6@CCM showed enhanced Ce6 release under acidic conditions and 808 nm irradiation, photothermal heating under 808 nm irradiation, and reactive oxygen species generation under 660 nm irradiation. Compared with uncoated nanoparticles, MnPB-PDA-Ce6@CCM showed increased uptake by A549 cells and reduced uptake by RAW264.7 macrophages. Following laser irradiation, the coated formulation produced the greatest inhibition of A549 cells, with an IC50 of 1.68 mu g/mL. In rats, MnPB-PDA-Ce6@CCM altered the pharmacokinetic behavior of Ce6 and delayed its clearance. These findings support further evaluation of this biomimetic platform for light-responsive Ce6 delivery.
The utilization of natural polysaccharides for the development of nanostructured systems aligns with the principles of green chemistry and environmental sustainability. This study reports the synthesis of novel polysaccharide-based nanocarriers comprising cellulose nanocrystal (CNCs) covalently conjugated with maltoheptaose (MH), serving as an efficient carrier for curcumin (CUR). Curcumin is a natural antibacterial agent and photosensitizer for bacterial photodynamic therapy; however, its practical application is limited by its low solubility, instability, as well as its low bioavailability. Cellulose nanocrystals were extracted from cotton linter, aminated and functionalized with MH via a reductive amination reaction to construct a CNC-based carrier for curcumin delivery. The prepared nanocarrier exhibited an entrapment efficiency of 90% and loading capacity of 6.8%. The in vitro release studies demonstrated pH and light sensitive release behavior with approximately 89% cumulative release at pH 5.4 under light irradiation after 24 h. Antibacterial activity evaluation under blue light irradiation revealed a 20-33% increase in inhibition zone diameters compared to dark conditions, confirming the enhanced antibacterial activity under light irradiation. The findings suggest that the MH-functionalize CNC (CNC-MH) provides an effective platform for curcumin loading and light-responsive antibacterial delivery.
A monolithic PLCL-based tissue sealant membrane (IIIb) is proposed. Via UV-initiated copolymerization, NHS-modified gelatin adhesive segments are covalently anchored onto the substrate, which differs from the conventional physically-laminated bilayer control (IIIa) and effectively avoids interfacial delamination. The optimized membrane achieves strong wet adhesion (8.15 KPa) and ultra-low 72 h swelling ratio of only 1.1%. Tunable degradation (4-36 weeks) is realized by adjusting PLCL dosage to match diverse soft tissue healing cycles. The membrane exhibits excellent cytocompatibility, hemocompatibility and negligible in vivo systemic toxicity. Ex vivo porcine organ defect tests confirm reliable burst pressure to meet clinical tissue sealing demands Clinically available tissue sealant membranes are limited by high swelling, poor flexibility, insufficient adhesion and high cost, restricting their use in complex surgeries. Herein, a novel monolithic embedded tissue sealant membrane (IIIb) was constructed via UV-initiated copolymerization. In this optimized formulation, NHS-modified gelatin adhesive moieties were covalently anchored onto one side of flexible PLCL-containing substrate, rather than simple physical lamination of two independent films (control sample IIIa prepared by method a). Although exhibiting a two-layer-like appearance, the resulting IIIb membrane forms an integral entity to suppress interfacial delamination. The composite membrane was prepared by sequential coating followed by UV photocrosslinking, and its chemical structure, morphology, adhesion, mechanics, swelling, degradation and biosafety were systematically evaluated. The optimized membrane showed an adhesive strength of 8.15 KPa, tensile strength of 4.9 MPa, elongation at break of 116.7%, and a low 72 h swelling ratio of 1.1%. Its degradation time was tunable from 4 to 36 weeks by regulating PLCL content to match soft tissue healing. In vitro and in vivo tests verified good cytocompatibility, hemocompatibility and negligible systemic toxicity with mild foreign body reaction. The membrane achieved a burst pressure of 11.5 +/- 1.2 kPa in an ex vivo porcine stomach perforation model, satisfying clinical sealing demands. This membrane overcomes the deficiencies of commercial counterparts and holds great potential for clinical tissue sealing.